Financing Growth at a Commercial P&C Brokerage

An RBF underwriter evaluating a brokerage's book of business will look closely at your renewal retention rate, what percentage of last year's commission revenue is still on the books this year, since that's the clearest signal of how durable the revenue actually is. A brokerage with strong, consistent retention across a diversified client base, not concentrated in one or two large accounts, is a meaningfully stronger candidate than one with either weak retention or heavy concentration, and it's worth presenting retention data by client segment, not just an aggregate number, since a lender will likely ask for that breakdown anyway.

Renewal commissions and new business commissions behave differently for underwriting purposes: renewals are the recurring piece an RBF provider can size an advance against with confidence, while new business commission, driven by how many new clients you sign in a given period, is more variable and closer to the one-off revenue pattern that's harder to finance this way. Present your revenue split between the two explicitly, since blending them into one number will likely get the whole application discounted as the lender tries to estimate the durable piece themselves.

Buying out a retiring producer's book of business, or funding an internal perpetuation plan where junior producers gradually acquire equity from founding partners, is a distinct transaction with its own financing shape, typically structured as a note against the specific book being transferred or a bank loan sized to the agency's overall cash flow, not RBF or venture debt as generally structured. This is one of the more common capital needs in this industry specifically, and specialty lenders exist who understand agency perpetuation financing well, which is usually a better starting point than trying to fit it into a growth-capital product built for a different purpose.

Acquiring another agency's book, whether a full agency purchase or buying a specific book of business from a retiring or exiting producer at another firm, is again its own transaction type, typically financed with acquisition debt sized against the acquired book's commission revenue and the purchase multiple, closer in structure to the DSO or veterinary group acquisition financing described elsewhere in this cluster than to RBF or venture debt against your existing renewal book.

Venture debt fits a brokerage that's raised institutional equity, typically an insurtech-adjacent brokerage building proprietary quoting, binding or client servicing technology, and wants corporate-level runway for that platform build rather than financing renewal commission growth itself, which RBF, if your renewal book is strong enough, can already address more cheaply and without diluting further.

Work through this before applying anywhere:

• Is your renewal retention strong and diversified enough that RBF against that piece specifically is realistic?
• Is the need agency perpetuation or a producer buyout, which needs specialty perpetuation financing rather than RBF or venture debt?
• Is it acquiring another agency's book, which needs acquisition-style financing sized against the target book?
• Have you raised institutional equity that would make venture debt relevant for a technology platform build?

Beyond client retention, a brokerage's revenue also depends on maintaining strong standing with the carriers it places business through, since a carrier relationship that sours, whether over loss ratios, volume commitments or service quality, can affect your ability to place and renew business even if your client relationships themselves are intact. A lender evaluating your renewal book closely enough to price RBF well may ask about carrier concentration and relationship health alongside client retention, and it's worth having that answer ready, with a clear view of your top carrier relationships and any recent shifts in placement volume, rather than assuming client retention data alone tells the whole story.